BeOne Medicines Stock Guidance

ONCNASDAQ

$241.20

-13.29-5.22%

At close: -

$245.00

3.801.58%

After Hours: Jun 27, 2:03 AM EDT

Guidance

BeOne Medicines issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

											Get Alert
05/07/2025	ONC	BeiGene	FY	2025	—	—	—	$4.90B	$5.30B	$5.09B	Get Alert
02/27/2025	ONC	BeiGene	FY	2025	—	—	—	$4.90B	$5.30B	$4.74B	Get Alert

There have been no specific sales or earnings guidance reported for BeOne Medicines in recent months.

Browse guidance and forecast on all stocks.